Brief: MGC Pharmaceuticals Secures $7.9 Million In Firm Commitments
01/11/2023 24:45
Nov 1 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* SECURES US$7.9 MILLION IN FIRM COMMITMENTS
* FUNDS SECURED REPRESENTS MINIMUM AMOUNT REQUIRED TO FUND
MGC
PHARMA'S FULL BUSINESS PLAN OVER NEXT 12-MONTH PERIOD
* PLACEMENT AT ISSUE PRICE OF US$0.255 PER SHARE
Source text for Eikon: ID:nASX7YRjrp
Further company coverage: MXC.AX
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group